Table of Contents

2019-2024 Global Nuclear Medicine Radioisotopes Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Consumption 2014-2024
2.1.2 Nuclear Medicine Radioisotopes Consumption CAGR by Region
2.2 Nuclear Medicine Radioisotopes Segment by Type
2.2.1 Thallium-201 (Tl-201)
2.2.2 Iodine (I-123)
2.2.3 Fluorine-18
2.2.4 Rubidium-82 (Rb-82)
2.2.5 Other
2.3 Nuclear Medicine Radioisotopes Consumption by Type
2.3.1 Global Nuclear Medicine Radioisotopes Consumption Market Share by Type (2014-2019)
2.3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2014-2019)
2.3.3 Global Nuclear Medicine Radioisotopes Sale Price by Type (2014-2019)
2.4 Nuclear Medicine Radioisotopes Segment by Application
2.4.1 Tumor
2.4.2 Heart Disease
2.4.3 Lymphoma
2.4.4 Thyroid Gland
2.4.5 Other
2.5 Nuclear Medicine Radioisotopes Consumption by Application
2.5.1 Global Nuclear Medicine Radioisotopes Consumption Market Share by Application (2014-2019)
2.5.2 Global Nuclear Medicine Radioisotopes Value and Market Share by Application (2014-2019)
2.5.3 Global Nuclear Medicine Radioisotopes Sale Price by Application (2014-2019)

3 Global Nuclear Medicine Radioisotopes by Players
3.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Players
3.1.1 Global Nuclear Medicine Radioisotopes Sales by Players (2017-2019)
3.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Players (2017-2019)
3.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Players
3.2.1 Global Nuclear Medicine Radioisotopes Revenue by Players (2017-2019)
3.2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Players (2017-2019)
3.3 Global Nuclear Medicine Radioisotopes Sale Price by Players
3.4 Global Nuclear Medicine Radioisotopes Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Nuclear Medicine Radioisotopes Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Nuclear Medicine Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Nuclear Medicine Radioisotopes by Regions
4.1 Nuclear Medicine Radioisotopes by Regions
4.1.1 Global Nuclear Medicine Radioisotopes Consumption by Regions
4.1.2 Global Nuclear Medicine Radioisotopes Value by Regions
4.2 Americas Nuclear Medicine Radioisotopes Consumption Growth
4.3 APAC Nuclear Medicine Radioisotopes Consumption Growth
4.4 Europe Nuclear Medicine Radioisotopes Consumption Growth
4.5 Middle East & Africa Nuclear Medicine Radioisotopes Consumption Growth

5 Americas
5.1 Americas Nuclear Medicine Radioisotopes Consumption by Countries
5.1.1 Americas Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
5.1.2 Americas Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
5.2 Americas Nuclear Medicine Radioisotopes Consumption by Type
5.3 Americas Nuclear Medicine Radioisotopes Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Nuclear Medicine Radioisotopes Consumption by Countries
6.1.1 APAC Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
6.1.2 APAC Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
6.2 APAC Nuclear Medicine Radioisotopes Consumption by Type
6.3 APAC Nuclear Medicine Radioisotopes Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Nuclear Medicine Radioisotopes by Countries
7.1.1 Europe Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
7.1.2 Europe Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
7.2 Europe Nuclear Medicine Radioisotopes Consumption by Type
7.3 Europe Nuclear Medicine Radioisotopes Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Nuclear Medicine Radioisotopes by Countries
8.1.1 Middle East & Africa Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
8.2 Middle East & Africa Nuclear Medicine Radioisotopes Consumption by Type
8.3 Middle East & Africa Nuclear Medicine Radioisotopes Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nuclear Medicine Radioisotopes Distributors
10.3 Nuclear Medicine Radioisotopes Customer

11 Global Nuclear Medicine Radioisotopes Market Forecast
11.1 Global Nuclear Medicine Radioisotopes Consumption Forecast (2019-2024)
11.2 Global Nuclear Medicine Radioisotopes Forecast by Regions
11.2.1 Global Nuclear Medicine Radioisotopes Forecast by Regions (2019-2024)
11.2.2 Global Nuclear Medicine Radioisotopes Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Nuclear Medicine Radioisotopes Forecast by Type
11.8 Global Nuclear Medicine Radioisotopes Forecast by Application

12 Key Players Analysis
12.1 Agfa-Gevaert Group
12.1.1 Company Details
12.1.2 Nuclear Medicine Radioisotopes Product Offered
12.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Agfa-Gevaert Group News
12.2 Braco
12.2.1 Company Details
12.2.2 Nuclear Medicine Radioisotopes Product Offered
12.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Braco News
12.3 Cardiarc
12.3.1 Company Details
12.3.2 Nuclear Medicine Radioisotopes Product Offered
12.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Cardiarc News
12.4 Cardinal Health
12.4.1 Company Details
12.4.2 Nuclear Medicine Radioisotopes Product Offered
12.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Cardinal Health News
12.5 CMR Naviscan (Gamma Medica Inc.)
12.5.1 Company Details
12.5.2 Nuclear Medicine Radioisotopes Product Offered
12.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 CMR Naviscan (Gamma Medica Inc.) News
12.6 Curium
12.6.1 Company Details
12.6.2 Nuclear Medicine Radioisotopes Product Offered
12.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Curium News
12.7 Digirad
12.7.1 Company Details
12.7.2 Nuclear Medicine Radioisotopes Product Offered
12.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Digirad News
12.8 GE Healthcare
12.8.1 Company Details
12.8.2 Nuclear Medicine Radioisotopes Product Offered
12.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 GE Healthcare News
12.9 Nordion (Canada)
12.9.1 Company Details
12.9.2 Nuclear Medicine Radioisotopes Product Offered
12.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Nordion (Canada) News
12.10 NTP Radioisotopes SOC
12.10.1 Company Details
12.10.2 Nuclear Medicine Radioisotopes Product Offered
12.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 NTP Radioisotopes SOC News
12.11 Positron
12.12 Segami
12.13 Siemens Healthcare

13 Research Findings and Conclusion